Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway.
OBJECTIVE
The regulation of apoptosis of intestinal mucosal cells is important in maintenance of normal intestinal physiology.


CONCLUSIONS
Sphingosine-1-phosphate (S1P) has been shown to play a critical role in cellular protection to otherwise lethal stimuli in several nonintestinal tissues.


METHODS
The current study determines whether S1P protected normal intestinal epithelial cells (IECs) from apoptosis and whether Akt activation was the central pathway for this effect.


RESULTS
S1P demonstrated significantly reduced levels of apoptosis induced by tumor necrosis factor-alpha (TNF-alpha)/cycloheximide (CHX). S1P induced increased levels of phosphorylated Akt and increased Akt activity, but did not affect total amounts of Akt. This activation of Akt was associated with decreased levels of both caspase-3 protein levels and of caspase-3 activity. Inactivation of Akt by treatment with the PI3K chemical inhibitor LY294002 or by overexpression of the dominant negative mutant of Akt (DNMAkt) prevented the protective effect of S1P on apoptosis. Additionally, silencing of the S1P-1 receptor by specific siRNA demonstrated a lesser decrease in apoptosis to S1P exposure.


CONCLUSIONS
These results indicate that S1P protects intestinal epithelial cells from apoptosis via an Akt-dependent pathway.
Greenspon
Jose
J
Department of Surgery, Cell Biology Group, Baltimore Veterans Affairs Medical Center, University of Maryland School of Medicine, 10 N. Greene Street, Baltimore, MD 21201, USA.
Li
Ruiyun
R
Xiao
Lan
L
Rao
Jaladanki N
JN
Marasa
Bernard S
BS
Strauch
Eric D
ED
Wang
Jian-Ying
JY
Turner
Douglas J
DJ
D000818:Animals; D017209:Apoptosis; D053148:Caspase 3 / Q000378:metabolism; D002460:Cell Line; D004789:Enzyme Activation; D004847:Epithelial Cells / Q000502:physiology*; D007413:Intestinal Mucosa / Q000502:physiology*; D008246:Lysophospholipids / Q000502:physiology*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism*; D034622:RNA Interference; D051381:Rats; D049349:Receptors, Lysosphingolipid / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000502:physiology; D014162:Transfection
D053148:Caspase 3; D008246:Lysophospholipids; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D051057:Proto-Oncogene Proteins c-akt; D049349:Receptors, Lysosphingolipid; D013110:Sphingosine; C060506:sphingosine 1-phosphate